| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $27.1M | $22.6M | $25.1M |
| YoY Revenue Growth % | +19.7% | -10.0% | — |
| Gross Profit | $9.8M | $9.9M | — |
| Gross Margin % | 36.3% | 43.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$8.2M | -$4.5M | -$4.4M |
| Operating Margin % | -30.5% | -20.0% | -17.6% |
| Net Income (GAAP) | -$8.2M | -$4.8M | -$4.6M |
| EBITDA (Normalized) | -$7.9M | -$3.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$9.9M | $4.1M | -$817.8K |
| Capital Expenditures (CapEx) | $400.8K | $969.2K | — |
| Free Cash Flow (FCF) | -$10.3M | $3.1M | -$817.8K |
| FCF Margin % | -38.1% | 13.7% | -3.3% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $12.4M | $5.4M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $21.6M | $10.2M | — |